[{"Assets_0_Q1_USD":191376000.0,"CommonStockSharesOutstanding_0_Q1_shares":143368784.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-28022000.0,"StockholdersEquity_0_Q1_USD":134082000.0,"Ticker":"CLDX","CIK":"744218","name":"CELLDEX THERAPEUTICS, INC.","OfficialName":"Celldex Therapeutics Inc.","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1601609341.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20180510"}]